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Abstract
Background
The post-resuscitation phase after out-of-hospital cardiac arrest (OHCA) is characterised
by a systemic inflammatory response (e.g., severe sepsis), for which the immature granulo-
cyte count is a diagnostic marker. In this study we evaluated the prognostic significance of
the delta neutrophil index (DNI), which is the difference in leukocyte subfractions as as-
sessed by an automated blood cell analyser, for early mortality after OHCA.
Materials and Methods
OHCA records from the emergency department cardiac arrest registry were retrospectively
analysed. Patients who survived at least 24 h after return of spontaneous circulation were
included in the analysis. We evaluated mortality and cerebral performance category scores
at 30 days.
Results
A total of 83 patients with OHCA were included in the study. Our results showed that DNI
>8.4% on day 1 (hazard ratio [HR], 3.227; 95% CI, 1.485–6.967; p = 0.001) and DNI
>10.5% on day 2 (HR, 3.292; 95% CI, 1.662–6.519; p<0.001) were associated with in-
creased 30-day mortality in patients with OHCA. Additionally, DNI>8.4% on day 1 (HR,
2.718; 95% CI, 1.508–4.899; p<0.001) and DNI>10.5% on day 2 (HR, 1.709; 95% CI,
1.051–2.778; p = 0.02) were associated with worse neurologic outcomes 30 days after
OHCA.
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Conclusion
A higher DNI is a promising prognostic marker for 30-day mortality and neurologic outcomes
after OHCA. Our findings indicate that patients with elevated DNI values after OHCA might
be closely monitored so that appropriate treatment strategies can be implemented.
Introduction
The incidence of out-of-hospital cardiac arrest (OHCA) in United States has increased from
295,000 cases in 2009 to approximately 424,000 cases in 2011.[1,2] In the early post-resuscita-
tion phase after OHCA, the complex pathophysiological processes of post-cardiac arrest syn-
drome involve a systemic inflammatory response (e.g., severe sepsis).[3–6] Sepsis-related
physiologic derangements are an important cause of early mortality in resuscitated patients.
[4,5,6] Currently there are no widely accepted prognostic factors to predict the severity of sep-
sis or mortality in resuscitated patients during this early critical period.
Immature granulocytes are an indicator of increased myeloid cell production and are associ-
ated with infection or systemic inflammation.[7–10] Although the immature granulocyte
count is a marker for septic conditions, this measure is difficult to use in clinical practice be-
cause manual counting is not accurate.[7,8] Recently, Nahm et al. developed the delta neutro-
phil index (DNI), which is the difference in leukocyte subfractions as assessed by an automated
blood cell analyser.[9] This method determines the fraction of circulating immature granulo-
cyte as the difference between the leukocyte subfraction determined by the cytochemical mye-
loperoxidase reaction and the leukocyte subfraction determined in a nuclear lobularity assay by
the reflected light beam.[9,10]
Recent studies suggest that the DNI is associated with positive blood culture results, dissem-
inated intravascular coagulation, and mortality in critically ill patients with suspected sepsis.
[8,9,10] Because patients resuscitated after cardiac arrest experience post-cardiac arrest syn-
drome, which includes sepsis-like physiologic derangement, the DNI may be associated with
early mortality or neurologic outcomes. Therefore, in this study we evaluated DNI values of pa-
tients resuscitated after cardiac arrest to determine the prognostic significance of DNI as a
marker for early mortality after OHCA.
Materials and Methods
This study was approved by the institutional review board of Yonsei University College of
Medicine, Gangnam Severance Hospital and performed between March 2010 and November
2012 at an urban hospital affiliated with our institution. Patients’ records and information
were anonymized and de-identified prior to analysis as retrospective study. This hospital has
an emergency department census of 60,000 patients per year. We retrospectively analysed
OHCA records from the emergency department cardiac arrest registry, screening all patients
who experienced return of spontaneous circulation (ROSC) after OHCA. Those who survived
at least 24 h after ROSC were included in the analysis. Exclusion criteria were age<18 years,
traumatic OHCA, and OHCA related to a drug overdose, hanging, or asphyxia. Management
of patients with OHCA was based on the 2010 European resuscitation council/American Heart
Association guidelines.
Upon arrival at the emergency department, all patients immediately had blood drawn for
the routine blood sampling set and were managed according to the resuscitation protocol of
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our institution. We extracted traditional Utstein template data from the emergency department
cardiac arrest registry including age, sex, patient identifier, the underlying significant co-mor-
bidities (hypertension, diabetic mellitus, pulmonary disease, malignancy, cardiovascular dis-
ease, renal disease, the presence of a prior acute coronary syndrome,), date of arrest, location of
arrest (public location or not), witnessed, bystander cardiopulmonary resuscitation (CPR), pre-
hospital ROSC, emergency medical services (ambulance or not), first monitored rhythm
(shockable or nonshockable), the use of antibiotic prophylaxis and inotrophics, the Acute
Physiology and Chronic Health Evaluation II (APACHE II) score on admission, therapeutic
hypothermia, survived event, pre-hospital ROSC, end of event, and cause of arrest. Serum DNI
was measured on day 1 (blood drawn immediately on emergency department admission), day
2 (24 h after admission), and day 3 (48 h after admission), and peak DNI (highest DNI value
during the hospital stay) was determined. Other laboratory tests including cell count, blood
urea nitrogen, creatinine, red cell distribution width, and albumin were carried out using the
initial blood specimens collected at emergency department admission.
DNI was automatically determined by an automated blood cell analyser (ADVIA 2120, Sie-
mens, Forchheim, Germany) using the following formula: DNI = (neutrophil subfraction and
eosinophil subfraction measured in the myeloperoxidase channel)–(polymorphonuclear sub-
fraction measured in the nuclear lobularity channel) [9,10] Post-resuscitation care was per-
formed in accordance with the 2005 and 2010 American Heart Association Guidelines for
Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Clinical outcomes were mortality and cerebral performance category (CPC) score at 30
days. CPC scores of 1 or 2 indicated favourable outcomes, whereas CPC scores of 3 to 5 indicat-
ed poor outcomes; a CPC score of 5 was assigned to patients who remained comatose and died
during the hospital stay or within 30 days after OHCA. Patients who were discharged or trans-
ferred to other hospital were interviewed by telephone within 30 days after OHCA.
Statistical analysis
Demographic and clinical data are presented as median (range) or frequency, as appropriate.
Continuous variables were compared by independent two-sample t-test, and categorical vari-
ables were compared by chi-squared test or Fisher exact test. Univariate analysis was carried to
evaluate relationships among demographic characteristics, Utstein variables, 30-day mortality,
and 30-day CPC score. Multivariate Cox proportional hazard regression analysis was con-
ducted to identify independent prognostic factors, and results were expressed as hazard ratios
(HRs) and 95% confidential intervals (CIs). We selected age and sex as known clinically impor-
tant variables. To highlight independent indicators of outcomes, we used a multivariate Cox
proportional hazard regression analysis integrating major covariates (selected here as variables
with a P< 0.1) indicated from our univariate analysis. In our study, we analyzed initial rhythm
as a significant variable (P< 0.1) together with age and sex. Mean DNI values were compared
between patient groups with respect to 30-day mortality (surviving versus non-surviving) and
neurologic outcomes (good versus poor).
Kaplan–Meier analysis survival curves were generated based on 30-day mortality and
30-day CPC scores, and the groups were compared by the log-rank test. Previous studies about
DNI in sepsis simply predicted cut-off points based on only events.[7–11] However, our study
made careful effort to predict the optimal cut-off point based on time to events through by
using the Contal and O’Quigley technique. This technique was used to select the cut-off value
of DNI for dichotomization of outcome variables. The optimal cut-off point was selected by
maximizing the hazard ratio.[12] A post-hoc statistical power calculation was performed using
a hazard ratio assumed to be α = 0.05; we had 86% and 87% post-hoc power to detect a hazard
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ratio (3.227, 3.292) of DNI1, DNI2 aspect to mortality. Statistical analyses were carried out
using SAS version 9.2 (SAS Institute Inc., Cary, NC); p<0.05 was considered significant.
Results
Of the 517 patients with OHCA registered in the emergency department cardiac arrest registry
during the study period, sustained ROSC was achieved in 183 (35.4%) patients. A total of 101
(19.5%) patients survived at least 24 after ROSC. However, 18 patients were excluded from the
analysis because of age<18 years (n = 9), traumatic OHCA (n = 8), or OHCA related to hang-
ing (n = 1). The remaining 83 (16.1%) eligible patients were stratified according to mortality
and neurologic outcomes at 30 days (Table 1). Thirty-four of the 83 subjects (41.0%) survived,
and 12 (14.5%) showed good outcomes (CPC score 1 or 2) at 30 days after OHCA. DNI values
on day 1, 2, and 3 and peak DNI differed significantly between the two patient groups.
The univariate Cox proportional hazard model revealed that higher DNI values on days 1,
2, and 3 were strong risk factors for mortality and poor neurologic outcomes at 30 days after
OHCA (Table 2). The multivariate Cox proportional hazard model also showed that increased
DNI values on day 1, 2, and 3 and peak DNI were independent predictors of mortality 30 days
after OHCA, and DNI values on days 1 and 2 were independent predictors of poor neurologic
outcomes (Table 3).
Mean DNI values differed significantly between groups with respect to 30-day mortality
and neurologic outcomes (Fig. 1). Kaplan–Meier curves were generated for 30-day mortality
and neurologic outcomes based on DNI values on day 1 and 2, and results of the log-rank test
indicated that these DNI values were independent prognostic factors in OHCA (Fig. 2). Opti-
mal day 1 DNI cut-off values were 8.4% (p = 0.01) for 30-day mortality and 8.4% (p = 0.01) for
30-day neurologic outcomes, and optimal day 2 DNI cut-off values were 12.9% (p<0.001) for
30-day mortality and 10.5% (p = 0.004) for 30-day neurologic outcomes.
Taken together, results of the Contal and O’Quigley technique, Kaplan–Meier analysis, and
log-rank test by considering time to event demonstrated that increased 30-day mortality in pa-
tients with OHCA was associated with DNI>8.4% on day 1 (HR, 3.227; 95% CI, 1.485–6.967;
p = 0.001) and>12.9% on day 2 (HR, 3.292; 95% CI, 1.662–6.519; p<0.001). In addition, poor
neurologic outcomes were associated with DNI>8.4% on day 1 (HR, 2.718; 95% CI, 1.508–
4.899; p<0.001) and>10.5% on day 2 (HR, 1.709; 95% CI, 1.051–2,778; p = 0.02).
Discussion
In this study we found that DNI in the early post-resuscitation phase after OHCA could be an
independent predictor of 30-day mortality and neurologic outcomes. Our results suggest that
patients with ROSC after cardiac arrest should be carefully monitored if the DNI value exceeds
8.4%. Similarly, a previous study by Park et al. reported that DNI>6.5% was a good diagnostic
marker of severe sepsis and septic shock within the first 24 hours after intensive care unit ad-
mission.[10] In our study, the cut-off value for DNI to predict mortality in OHCA was higher
than the value reported in other critical settings like severe sepsis or septic shock. After post-re-
suscitation, most patients may present with a more severe clinical course compared to patients
with severe sepsis or septic shock.
Nolan et al. proposed post-cardiac arrest syndrome as a second, more complex phase of re-
suscitation in patients who achieved ROSC after cardiac arrest.[5,6] Both infectious and sterile
injuries (e.g., ischaemia/reperfusion) initiate and propagate the systemic inflammatory re-
sponse and organ damage. [13] During infection or stress, immature neutrophil forms enter
the circulation. The elevated immature/total granulocyte ratio, referred to as a left-shift,[10] is
therefore a marker of infection or systemic inflammation. An increase in immature
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granulocytes is also included in the criteria of systemic inflammatory response syndrome
(SIRS). [7] Previous studies have described DNI as a useful prognostic factor for severity of sep-
sis and septic shock, positive blood culture results, disseminated intravascular coagulation, and
mortality.[8,9,10] Recent studies suggest that sepsis is able to impair innate immunity.[7,10]
Table 1. Baseline characteristics of patients stratified according to 30-daymortality and neurologic outcomes.
Variables Total 30-day Mortality 30-day CPC score 30-day CPC score
Death (n = 49) Survival (n = 34) p-value Good (n = 12) Poor (n = 71) p-value
Age, years 61.4±15.9 59.2±17.2 64.6±13.5 0.13 45±18.0 64.2±13.8 <0.001*
Sex (Female) 20 (23.1) 10 (20.4) 10 (29.4) 3 (25.0) 17 (23.9) >0.999
Hypertension 36 (43.4) 22 (44.9) 14 (41.2) 0.737 3 (25.0) 33 (46.5) 0.165
Diabetic mellitus 24 (28.9) 12 (24.5) 12 (35.3) 0.286 2 (16.7) 22 (31.0) 0.494
Pulmonary disease 3 (3.6) 3 (6.1) 0 (0.0) 0.266 1 (8.3) 2 (2.8) 0.378
Malignancy 4 (4.8) 2 (4.1) 2 (5.9) >0.999 0 (0.0) 4 (5.6) >0.999
Cardiovascular disease 20 (24.1) 13 (26.5) 7 (20.6) 0.534 3 (25) 17 (23.9) >0.999
Previous ACS 7 (8.4) 5 (10.2) 2 (5.9) 0 0.695 1 (8.3) 6 (8.5) >0.999
Renal disease 13 (15.7) 9 (18.4) 4 (11.8) 0.416 0 (0.0) 13 (18.3) 0.198
Cardiac origin 47 (56.6) 30 (61.2) 17 (50.0) 0.31 10 (83.3) 37 (52.1) 0.444
Cardiac arrest in public place 35 (42.7) 22 (44.9) 13 (39.4) 0.621 4 (33.3) 31 (44.3) 0.478
Pre-hospital ROSC 1 (1.2) 1 (2.0) 0 (0.0) >0.999 1 (8.3) 0 (0.0) 0.145
Initial rhythm shockable 22 (26.5) 17 (34.7) 5 (14.7) 0.043* 8 (66.7) 14 (19.7) 0.002*
Total CPR time in hospital, min 13.5±11.2 12.8±10.5 14.5±12.3 0.496 14.3±12.9 13.3±11.0 0.793
Arrest time, min 31.0±15.6 29.3±14.7 33.4±16.9 0.243 35.1±15.9 30.3±15.6 0.323
Bystander CPR 19 (23.5) 10 (20.8) 9 (27.3) 0.502 3 (25.0) 16 (23.2) >0.999
Hypothermia 44 (53.0) 27 (55.1) 17 (50.0) 0.647 6 (50.0) 38 (53.5) 0.821
Witness 31 (37.35) 17 (34.69) 14 (41.18) 0.548 4 (33.33) 27 (38.03) >0.999
BUN, mg/dL 26.6±19.2 28.0±22.4 24.6±13.1 0.39 21.9±22.0 27.4±18.7 0.36
Cr, mg/dL 2.6±3.2 2.9±3.7 2.2±2.2 0.244 1.4±0.7 2.8±3.4 0.002*
Albumin, g/dL 3.4±0.7 3.5±0.6 3.3±0.9 0.296 3.6±0.8 3.4±0.7 0.393
Platelet count 139.5±64.9 173.0±53.3 109.8±61.7 0.04* 152.3±67.4 135.6±66.4 0.668
Haematocrit, % 40.3±9.3 40.4±9.3 40.1±9.4 0.905 43.3±13.1 39.8±8.5 0.387
RDW day 1, % 13.9±1.6 13.8±1.6 14.1±1.5 0.285 13.2±1.0 14.0±1.6 0.087
WBC day 1 14,841.3±7642.2 16,678.6±8255.9 12,193.5±5809.1 0.005* 16,085.8±8692.0 14,631.0±7498.8 0.545
DNI day 1, % 5.3±9.1 3.6±5.1 7.7±12.5 0.076 2.3±2.9 5.8±9.6 0.02*
DNI day 2, % 10.7±12.8 7.5±7.9 15.3±16.8 0.015* 7.0±6.8 11.3±13.5 0.099
DNI day 3, % 8.3±9.7 5.3±6.3 15.3±12.5 0.003* 4.3±3.9 9.2±10.4 0.009*
DNI day peak, (%) 14.3±14.4 10.9±11.1 20.8±17.7 0.017* 8.0±6.4 15.7±15.3 0.008*
DNI peak, day (day) 3.1±3.7 2.5±2.0 4.2±5.6 0.17 2.7±3.0 3.2±3.9 0.635
Antibiotics prophylaxis 50 (82.0) 41 (85.4) 9 (69.2) 0.226 11(91.7) 39 (79.6) 0.438
Inotrophics 44 (72.1) 35 (72.9) 9 (69.2) >0.999 8 (66.7) 36 (73.5) 0.723
APACHE II 19.0±5.7 18.7±6.3 19.5±4.7 0.508 17.1±7.4 19.3±5.3 0.209
CPC: cerebral performance category, ACS: acute coronary syndrome, ROSC: return of spontaneous circulation, CPR: cardiopulmonary resuscitation,
BUN: blood urea nitrogen, Cr: creatinine, RDW: red cell distribution width, APACHE II:Acute Physiology and Chronic Health Evaluation II, DNI: delta
neutrophil index
*: p<0.05.
doi:10.1371/journal.pone.0120677.t001
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However, it is unclear how sterile injury activates innate immunity in the absence of foreign in-
vaders.[5,6]
Whole-body ischaemia/reperfusion after cardiac arrest activates immunological and coagu-
lation pathways, increasing the risk of infection and multiple organ failure. In the early phase
(within 3 h after cardiac arrest), blood levels of cytokines, soluble receptors, and endotoxin are
elevated. These changes are associated with clinically poor outcomes.[5,6] In sepsis, the over-
production of nitric oxide (NO), chemokines, and cytokines reduces chemotaxis and adhesion
Table 2. Univariate Cox proportional analysis for 30-day mortality and neurologic outcomes.
Variables 30-day Mortality 30-day CPC score
HR 95% CI p-value HR 95% CI p-value
Age 1.028 1.005–1.054 0.016* 1.028 1.012–1.045 <0.001*
Sex (Female) 1.235 0.589–2.587 0.577 0.895 0.518–1.547 0.691
Hypertension 1.069 0.539–20123 0.8479 1.303 0.815–2.082 0.2691
Diabetic mellitus 1.42 0.697–2.889 0.3339 1.286 0.773–2.140 0.3326
Pulmonary disease 0.443 0.025–7.791 0.5782 0.782 0.191–3.204 0.7323
Malignancy 1.507 0.359–6.324 0.575 1.622 0.588–4.479 0.3504
Cardiovascular disease 0.837 0.364–1.924 0.6751 1.041 0.603–1.798 0.8842
Previous ACS 0.635 0.151–2.661 0.534 1.033 0.444–2.404 0.9403
Renal disease 0.573 0.201–1.630 0.2964 0.868 0.473–1.592 0.6478
Cardiac origin 0.748 0.381–1.469 0.3996 0.8/76 0.548–1.399 0.5788
Cardiac arrest in public place 0.969 0.48–1.955 0.93 1.254 0.781–2.015 0.349
Prehospital ROSC 2.068 0.114–37.356 0.623 2.068 0.114–37.356 0.623
CPR rhythm (Shockable) 0.414 0.16–1.07 0.069 0.574 0.32–1.031 0.063
Total CPR time in hospital 1.009 0.981–1.038 0.533 1.003 0.982–1.024 0.793
Arrest time 1.014 0.993–1.036 0.188 1.003 0.989–1.018 0.646
Bystander CPR 1.719 0.793–3.727 0.17 1.461 0.831–2.567 0.188
Hypothermia 0.741 0.378–1.455 0.384 0.809 0.506–1.292 0.374
Witness 1.338 0.674–2.656 0.405 1.224 0.756–1.982 0.41
BUN, mg/dL 0.992 0.974–1.01 0.375 0.997 0.986–1.007 0.536
Cr, mg/dL 0.924 0.815–1.048 0.219 0.978 0.914–1.046 0.512
Albumin, g/dL 0.69 0.432–1.102 0.12 0.803 0.569–1.131 0.209
Platelet count 0.989 0.978–1 0.057 0.995 0.985–1.005 0.30
Haematocrit, % 0.997 0.964–1.031 0.853 0.995 0.973–1.018 0.673
RDW day 1, % 1.125 0.928–1.363 0.232 1.075 0.938–1.232 0.30
WBC day 1 0.951 0.895–1.010 0.102 1.020 0.952–1.056 0.263
DNI day 1, % 1.049 1.02–1.08 0.001* 1.041 1.016–1.066 0.001*
DNI day 2, % 1.036 1.015–1.057 <0.001* 1.021 1.003–1.039 0.023*
DNI day 3, % 1.082 1.042–1.124 <0.001* 1.026 0.998–1.055 0.072
DNI day peak, (%) 1.031 1.01–1.052 0.004* 1.012 0.996–1.029 0.142
DNI peak, day (day) 1.046 0.977–1.12 0.196 1.01 0.942–1.082 0.787
Antibiotics prophylaxis 0.568 0.174–1.852 0.3485 0.966 0.482–1.938 0.9235
Inotrophics 0.859 0.264–2.792 0.8 1.055 0.559–1.991 0.8686
APACHE II 1.01 0.957–1.066 0.7183 0.998 0.962–1.036 0.9277
CPC: cerebral performance category, ACS: acute coronary syndrome, ROSC: return of spontaneous circulation, CPR: cardiopulmonary resuscitation,
BUN: blood urea nitrogen, Cr: creatinine, RDW: red cell distribution width, APACHE II: Acute Physiology and Chronic Health Evaluation II, DNI: delta
neutrophil index
*: p<0.05.
doi:10.1371/journal.pone.0120677.t002
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interactions between neutrophils and the endothelium. Alves-Filho et al. suggest neutrophil pa-
ralysis to be characterized by the failure of neutrophils to migrate into the site of infection, and
inappropriate neutrophil sequestration in remote organs.[14]
We believe that post-cardiac arrest syndrome is comparable with sepsis or SIRS. In post-car-
diac arrest syndrome, elevated P- and E-selectin, soluble vascular cell adhesion molecule-1, and
Fig 1. Mean delta neutrophil index (DNI) values associated with mortality (A) and neurologic outcomes (B) at 30 days.Days: Days after out-of-
hospital cardiac arrest.
doi:10.1371/journal.pone.0120677.g001
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soluble intercellular molecule-1 are observed after CPR.[6,15] Elevated adhesion molecules in-
dicate neutrophil activation and subsequent endothelial injury.[6,15] The hyporesponsiveness
of circulating leukocytes, like neutrophil paralysis in patients with systemic inflammatory re-
sponse syndrome, appears to protect against the overwhelming pro-inflammatory response.
[6,15]
Although the mechanisms underlying the increase in immature granulocytes after post-re-
suscitation are unclear, we hypothesize that neutrophil paralysis in post-cardiac arrest syn-
drome leads to interactions between adhesion molecules and activated neutrophils causing
decreased circulating neutrophils. The subsequent hyporesponsiveness of circulating leuko-
cytes may require more activated neutrophils after ischaemia/reperfusion injury. Therefore,
levels of immature neutrophils may be increased by the requirement for circulating activated
neutrophils after post-resuscitation. It is unlikely that the elevated DNI in the early post-resus-
citation phase is the result of infection because the DNI value on day 1 was determined from
blood drawn before or immediately after ROSC. Therefore, the observed elevation in DNI is
likely the result of sterile inflammation.
Fig 2. Delta neutrophil index as a predictor of mortality and neurologic outcomes at 30 days after out-of-hospital cardiac arrest. The technique of
Contal and O’Quigley based on the log-rank test was used to assess prognostic value of the delta neutrophil index (DNI) by considering time to event. Cut-off
points for DNI measured on day 1 were (A) DNI>8.4 (p = 0.01), HR = 3.227 (95%CI, 1.495–6.967; p = 0.001) for 30-day mortality and (B) DNI>8.4
(p = 0.01) HR = 2.718 (95%CI, 1.508–4.899; p<0.001) for neurologic outcomes at 30 days. Cut-off points for DNI measured on day 2 were (C) DNI>12.9
(p<0.001), HR = 3.292 (95%CI, 1.662–6.519; p<0.001) for 30-day mortality and (D) DNI>10.5 (p = 0.004), HR = 1.709 (1.051–2.778; p = 0.02) for
neurologic outcomes at 30 days. Duration: Days after out-of-hospital cardiac arrest.
doi:10.1371/journal.pone.0120677.g002
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Procalcitonin and C-reactive protein have been widely used as biomarkers in critical care.
[11,16] Although C-reactive protein and procalcitonin can increase the likelihood of a sepsis
diagnosis,[17] Procalcitonin is associated with poor long-term neurologic outcomes and mor-
tality in patients achieving ROSC after OHCA; however, C-reactive protein was not associated
with outcomes.[16] In addition, elevated levels of procalcitonin and C-reactive protein do not
correlate with infection in the early stage of post-cardiac arrest syndrome.[16]
In this study we used an automated blood cell analyser to determine DNI, which overcomes
the limitation of manual counting of immature granulocytes. The immature granulocyte
counts may be inconsistent with the results from other analyzers that use different methods to
determine differential leukocyte counts. Ha et al. demonstrated that an elevated immature
granulocyte % (IG%) of more than 2.0–3.0% in the Sysmex system could be detected for sepsis
using different methods. [18] However, that study revealed that IG% could not estimate the se-
verity of sepsis due to the inability of this method to predict 28-day mortality. [18]
While immature granulocytes have been measured using various equipment and statistical
approaches, the majority of published studies use ADVIA to measure immature granulocytes.
[18] DNI value has been accurately measured using a simple two-step procedure and staining
of cytochemical myeloperoxidase compared to other analyzers. Firstly, this ADVIA analyzer
analyzes the leukocyte differentials by cytochemical myeloperoxidase (MPO) reaction. Next,
this machine confirms the nuclear lobularity of white blood cells by a light beam for accurate
fraction of immature granulocytes in circulating blood. [9] Nahm et al. clearly demonstrated in
using this approach, DNI strongly correlated with manual immature granulocyte counts. [9]
Therefore, the assessing DNI using the ADVIA device may best reflect immature granulocyte
counts compared to all available analyzers.
In addition, DNI can be analysed along with the complete blood count, which is routinely
performed in critically ill patients,[8] requiring no additional time or cost unlike C-reactive
protein and procalcitonin. Changes in DNI over time may also be promising marker for the ef-
fects for therapeutic hypothermia, and Pyo et al. demonstrated that DNI could discriminate be-
tween a disease flare-up and infection in systemic lupus erythematous [19] and we proposed
that DNI may be promising marker for development of sepsis during post-resuscitation care.
In future, prospective multicentre studies with a larger number of patients will be needed to
confirm our findings that DNI is a promising marker prediction of prognosis after ROSC and
discrimination between severe sepsis and post-cardiac arrest syndrome during post-
resuscitation care.
Study limitations
This study has several limitations. First, this was a single-centre retrospective study, raising the
possibility of selection bias. Second, the sample size was relatively small because we included
only patients who survived at least 24 h and had at least two serum DNI measurements in the
acute phase (24–48 h), and the rates of ROSC and survival after OHCA are lower in our coun-
try than in developed countries. However, statistically, repeated measurements of DNI over
time in one subject could improve statistical power and compensate for the small sample size
in this study. Third, this study did not evaluate haemodynamic parameters, presence of infec-
tion, or organ function to investigate the mechanisms underlying changes in DNI in the early
post-resuscitation phase. Fourth, although our study revealed that DNI in the early post-resus-
citation phase was associated with 30-day mortality and neurologic outcomes, we were unable
to assess long-term neurologic outcomes in OHCA patients. In conclusion, a higher DNI is a
promising prognostic marker for 30-day mortality and neurologic outcomes after OHCA.
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Patients with elevated DNI on day 1 and day 2 after OHCA might be closely monitored so that
appropriate treatment strategies can be implemented.
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